RDGL 8-K 2026-10-05

VIVOS INC (RDGL) 8-K dated 2026-10-05 — accession 0001493152-26-045780.

VIVOS INC (RDGL) is a medical devices company listed on US.

VIVOS INC filed a 8-K on 2026-10-05. Accession 0001493152-26-045780.

This 8-K covers: Bylaws or fiscal year change (Item 5.03), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported RDGL revenue for 2025-12-31 was $68.4K. Net income was -$3.1M. Revenue was up 250.7% from 2023-12-31 to 2025-12-31. RDGL currently screens at market cap $54.0M.

Not investment advice. The RDGL SEC hub lists recent forms. The stock page is the research view.